13 patents
Utility
Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
10 Oct 23
Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions using solventless mixing methods.
Rosaleen McLaughlin, Simon Andrew Martyn Howes, Craig Wheadon, Jonathon Whitehouse
Filed: 4 May 21
Utility
Oral dispersible vaccine comprising virosomes
13 Dec 22
The present disclosure is directed to oral vaccine dosage forms and processes for producing the oral vaccine dosage forms.
Yik Teng Wong, Charli Smardon, Khojasteh Shirkhani, Mario Amacker, Sylvain Fleury, Antonius Johannes Hendrikus Stegmann
Filed: 26 Nov 19
Utility
Compositions of different densities for fast disintegrating multi-layer tablet
6 Dec 22
Described herein is a method for forming multi-layer drug dosage forms having at least two layers.
Leon Paul Grother, Keiko Tsutsumi, Rosaleen Theresa McLaughlin, Yik Teng Wong
Filed: 25 Oct 17
Utility
Oral dispersible vaccine comprising virosomes
18 Jan 22
The present disclosure is directed to oral vaccine dosage forms and processes for producing the oral vaccine dosage forms.
Yik Teng Wong, Charli Smardon, Khojasteh Shirkhani, Mario Amacker, Sylvain Fleury, Antonius Johannes Hendrikus Stegmann
Filed: 23 Aug 21
Utility
Density flow meter for pharmaceutical formulation dosing
30 Nov 21
Provided are systems and method for dosing a pharmaceutical formulation.
David Waddington, Matthew Wort, Katherine Arneil
Filed: 30 Jul 20
Utility
Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
30 Nov 21
Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions that preserve the coating of coated API particles in a pharmaceutical suspension.
Rosaleen McLaughlin, Adam Parker, Jonathon Whitehouse
Filed: 21 Feb 20
Utility
Multiphase soft gel capsules, apparatus and method thereof
16 Nov 21
A multi phase soft gelatin dosage form comprising at least one preformed solid dosage form and at least one liquid fill phase.
Peter Robert Draper, James Edward Draper, Beth Okutan
Filed: 2 Nov 17
Utility
Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
9 Nov 21
Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions comprising Ibuprofen using solventless mixing methods.
Rosaleen McLaughlin, Simon Andrew Martyn Howes, Craig Wheadon, Jonathon Whitehouse, Adam Parker
Filed: 21 Feb 20
Utility
Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
12 Oct 21
Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions using solventless mixing methods.
Rosaleen McLaughlin, Simon Andrew Martyn Howes, Craig Wheadon, Jonathon Whitehouse
Filed: 21 Feb 20
Utility
Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
3 Aug 21
Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions comprising Ibuprofen using solventless mixing methods.
Rosaleen McLaughlin, Simon Andrew Martyn Howes, Craig Wheadon, Jonathon Whitehouse, Adam Parker
Filed: 31 Aug 20
Utility
Lyophilized pharmaceutical compositions for vaginal delivery
8 Jun 21
Disclosed herein is a solid lyophilized vaginal dosage form that can have an effective amount of at least one active ingredient, a crystalline structure forming agent in an amount of about 5 wt. % to about 40 wt. %, based on the total weight of the lyophilized dosage form, and at least one polymeric mucoadhesive matrix forming agent.
Emilie Masto, Lisa Garrett, Niamh Barrat, Yik Teng Wong, Rosaleen Theresa McLaughlin, Susan Gerrard Banbury
Filed: 13 Oct 17
Utility
Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
8 Jun 21
Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions using solventless mixing methods.
Rosaleen McLaughlin, Simon Andrew Martyn Howes, Craig Wheadon, Jonathon Whitehouse
Filed: 31 Aug 20
Utility
Process to reduce endotoxin in gelatin
27 Apr 21
The present disclosure is directed to processes for reducing the endotoxin level in gelatin and the resulting gelatin with low endotoxin content.
Yik Teng Wong, Khojasteh Shirkhani, Ami Powe, Sarah Stewart, Charli Smardon
Filed: 7 Mar 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first